GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabist Company Holdings Inc (NEOE:CBST) » Definitions » Debt-to-Equity

Cannabist Company Holdings (NEOE:CBST) Debt-to-Equity : 8.17 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Cannabist Company Holdings Debt-to-Equity?

Cannabist Company Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$30.8 Mil. Cannabist Company Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$702.2 Mil. Cannabist Company Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$89.7 Mil. Cannabist Company Holdings's debt to equity for the quarter that ended in Dec. 2023 was 8.17.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Cannabist Company Holdings's Debt-to-Equity or its related term are showing as below:

NEOE:CBST' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.31   Med: 0.96   Max: 8.17
Current: 8.17

During the past 6 years, the highest Debt-to-Equity Ratio of Cannabist Company Holdings was 8.17. The lowest was 0.31. And the median was 0.96.

NEOE:CBST's Debt-to-Equity is ranked worse than
98.48% of 856 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs NEOE:CBST: 8.17

Cannabist Company Holdings Debt-to-Equity Historical Data

The historical data trend for Cannabist Company Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabist Company Holdings Debt-to-Equity Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial 0.31 0.96 0.74 2.66 8.17

Cannabist Company Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.66 3.08 3.55 3.80 8.17

Competitive Comparison of Cannabist Company Holdings's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabist Company Holdings's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Cannabist Company Holdings's Debt-to-Equity falls into.



Cannabist Company Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Cannabist Company Holdings's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Cannabist Company Holdings's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabist Company Holdings  (NEOE:CBST) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Cannabist Company Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Cannabist Company Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabist Company Holdings (NEOE:CBST) Business Description

Traded in Other Exchanges
Address
680 Fifth Avenue, 24th Floor, New York, NY, USA, 10019
Cannabist Company Holdings Inc Formerly Columbia Care Inc is a cultivator, manufacturer, and provider of medical cannabis products and services. Some of its products are Vaporization Oil, Sublingual Tinctures, Lotions, Hard Pressed Tablets, and Suppositories, among others. The company markets its products under Amber, ClaraCeed, Press, Platinum label, Platinum Partners, Seed & Starin, and Triple 777 brands.

Cannabist Company Holdings (NEOE:CBST) Headlines

No Headlines